On ECHEMI
Home > Drugs > Pulmonary Nocardiosis
Pulmonary Nocardiosis
Nocardiosis is a purulent granulomatous disease caused by Nocardia. The lungs are the most commonly affected organ, with pulmonary and systemic nocardiosis accounting for about 85% of all nocardiosis. About half of pulmonary nocardiosis cases are accompanied by extrapulmonary lesions, while extrapulmonary nocardiosis causes dissemination in only one-fifth of cases.
  • Site of disease:

    lung
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Fever cough chest pain purulent sputum shortness of breath
Related Drugs
Compound sulfadiazine tablets
Indication: 1. Urinary tract infection caused by susceptible strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae.
Manufacturer:

Sichuan Kangteneng Pharmaceutical Co., Ltd.

Cisulan Tablets
Indication: It can relieve cough, eliminate phlegm and reduce inflammation. It is used for acute and chronic upper respiratory tract infections and lung infections.
Manufacturer:

NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

Cefadroxil Granules
Indication: It is mainly used for infectious diseases of the respiratory tract, reproductive and urinary tract, skin and soft tissue, digestive tract, etc. caused by Staphylococcus, Streptococcus, Pneumococcus, etc.
Manufacturer:

NCPC Hebei HUAMIN Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.